GC Biopharma Market Cap

GC Biopharma has a market cap or net worth of 1.48 trillion as of June 20, 2025. Its market cap has increased by 13.92% in one year.

Market Cap

1.48T

Enterprise Value

2.65T

Revenue

1.71T

Ranking

n/a

PE Ratio

51.37

Stock Price

129,300.00

Market Cap Chart

Since August 29, 1995, GC Biopharma's market cap has increased from 29.09B to 1.48T, an increase of 4,973.70%. That is a compound annual growth rate of 14.07%.

Market Cap History

Date	Market Cap	% Change
Jun 20, 2025	1,475.72B	-27.97%
Dec 30, 2024	2,048.67B	43.03%
Dec 28, 2023	1,432.35B	-3.09%
Dec 29, 2022	1,478.01B	-40.60%
Dec 30, 2021	2,488.07B	-46.31%
Dec 30, 2020	4,633.75B	206.42%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	72.31T
Celltrion	35.87T
ALTEOGEN	20.84T
Yuhan	7,750.90B
SK Biopharmaceuticals	7,275.30B
HLB Co., Ltd.	7,017.40B
PharmaResearch	4,748.07B
Peptron	4,647.82B

Market Cap Rankings